LumaCyte

9 articles about LumaCyte

• LumaCyte Launches New Compact Radiance® Instrument for Advanced Therapy Biomanufacturing & QC Environments

  10/24/2023

  LumaCyte is proud to announce the launch of their newly redesigned flagship Radiance® instrument to meet growing demand for Laser Force Cytology™ precision analytics in space-constrained biomanufacturing facilities.

• LumaCyte Accelerates Global Growth, Closing Strategic Series B Financing

  9/6/2023

  LumaCyte announced the closing of a B series financing that will further accelerate growth in the company’s automated bioproduction analytics solutions and expand its global infrastructure to meet growing demand.

• LumaCyte Fueled for Growth, Names Top Life Sciences Industry Executives to Board

  3/8/2022

  LumaCyte Corporation announced the successful completion of an A round financing that will allow the company to accelerate its global expansion efforts and service the increasing global demand of its flagship product, Radiance ®.

• LumaCyte Appoints Vaccine Manufacturing Expert to Scientific Advisory Board

  4/20/2021

  LumaCyte , a leader in advanced label-free single-cell analytics through its novel Laser Force Cytology™ (LFC™) platform, announces today the addition of Jim Robinson to its Scientific Advisory Board (SAB).

• LumaCyte’s Laser Force Cytology Accelerating Gene Therapy Production

  6/2/2020

  LumaCyte, an advanced bioanalytical instrumentation company has demonstrated a significant advancement using its transformative Laser Force Cytology instrument, Radiance®.

• LumaCyte Expands into Europe Tackling Expansive Vaccine and Cell and Gene Therapy Markets

  2/20/2020

  LumaCyte, an advanced bioanalytical instrumentation company specializing in vaccine and cell and gene therapy bioprocess, production, and R&D analytical capabilities, announces its expansion into Europe with the establishment of LumaCyte, B.V. in The Netherlands.

• LumaCyte Primed for Significant Global Growth: CE Mark Opens European Market

  9/12/2019

  LumaCyte, an advanced research and bioanalytics instrumentation company headquartered in Charlottesville, VA, announces the third doubling of their manufacturing and laboratory space.

• LumaCyte Joins The National Institute For Innovation In Manufacturing Biopharmaceuticals (NIIMBL)

  9/8/2017

• LumaCyte Invited For Keynote Presentation At NIWeek 2016

  8/3/2016